EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Antiherpes Simplex Virus Activities of Thiourea‐Based Compounds

Hiroki Kondo, Juri Koizumi iD, Keita Takahashi, Tetsuo Koshizuka iD

Microbiology and Immunology · 2025

DOI: 10.1111/1348-0421.70005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology and Immunology, 2025. Verfasst von Hiroki Kondo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical, Laboratory of Microbiology and Immunology, Gifu Pharmaceutical University, Gifu, Japan. Hauptthemen laut MEDLINE: Antiviral Agents, Herpesvirus 1, Human, Thiourea. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of drug‐resistant viruses, particularly in immunocompromised individuals, has necessitated the development of novel antiviral drugs. We previously identified compound 147B3 as an inhibitor of herpes simplex virus type 1 (HSV‐1) and human cytomegalovirus (HCMV). Although 147B3 exhibits cytotoxicity, it inhibits the function of infected cell protein 4 (ICP4), a viral transcription factor essential for HSV‐1 replication. In this study, we evaluated five commercially available compounds (1C6, 1C6L, 1H6, 1H6L, and 2D10) that had structural similarity to 147B3, exhibited potent anti‐HSV‐1 activity with reduced cytotoxicity. Among these, 1C6L and 1H6L are structural analogs of 1C6 and 1H6, respectively. An HSV‐1 strain resistant to 147B3 carrying a mutation in ICP4 exhibited resistance to all the five compounds, suggesting a shared mechanism of action involving ICP4. Among these compounds, 1H6L had the highest selective index against HSV‐1. Notably, these compounds did not reduce early or late protein expression of HSV‐1, unlike the parent compound 147B3. Although viral genome replication occurred in the presence of 1H6L, it prevented virion release into the culture supernatant. The cell fraction analysis revealed that 1H6L reduced the size of the cytoplasmic HSV‐1 genome. These findings suggest that 1H6L shares certain aspects of its mechanism of action with the parent compound 147B3 but may also inhibit multiple steps in the HSV‐1 life cycle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHerpesvirus 1, HumanThioureaVirus ReplicationChlorocebus aethiopsHumansVero CellsDrug Resistance, ViralAnimalsImmediate-Early ProteinsMicrobial Sensitivity TestsCell Line

Stichwörter der Autor:innen

HSV‐1ICP4antiviral compoundsthiourea structure

Substanzen

Antiviral AgentsThioureaImmediate-Early Proteinsherpes simplex virus, type 1 protein ICP4

Autor:innen und Institutionen

  • Department of Pharmaceutical, Laboratory of Microbiology and Immunology, Gifu Pharmaceutical University, Gifu, Japan.

ORCID-Profile: Juri Koizumi, Tetsuo Koshizuka

Zitieren

APA

Kondo, H., Koizumi, J., Takahashi, K., & Koshizuka, T. (2025). Evaluation of the Antiherpes Simplex Virus Activities of Thiourea‐Based Compounds. Microbiology and Immunology. https://doi.org/10.1111/1348-0421.70005

Vancouver

Kondo H, Koizumi J, Takahashi K, Koshizuka T. Evaluation of the Antiherpes Simplex Virus Activities of Thiourea‐Based Compounds. Microbiology and Immunology. 2025. doi:10.1111/1348-0421.70005

BibTeX
@article{Kondo2025,
  author = {Kondo, Hiroki and Koizumi, Juri and Takahashi, Keita and Koshizuka, Tetsuo},
  title = {Evaluation of the Antiherpes Simplex Virus Activities of Thiourea‐Based Compounds},
  journal = {Microbiology and Immunology},
  year = {2025},
  doi = {10.1111/1348-0421.70005}
}
Kostenlos starten →